Written and medically reviewed by: Assoc. Prof. Cengiz Dibekoğlu, MD, General SurgeryLast updated:
Hereditary Cancers — Li-Fraumeni Syndrome
TP53, multi-cancer risk, and careful imaging
Li-Fraumeni syndrome (LFS) is most often linked to pathogenic TP53 germline variants. Sarcoma, breast, brain, adrenocortical, and other cancers can cluster at young ages. For surgical teams, key points are avoiding unnecessary radiation when alternatives exist and opening genetic counseling early.
Educational schematic. Some structures may be simplified or emphasized for clarity; not an exact anatomical depiction.
© Cengiz Dibekoğlu — illustrative; not for unauthorized use
Figure summary
This educational figure shows: Li-Fraumeni.
Key points
When to raise the question
Very young-onset breast cancer or sarcoma, multiple primaries, or first-degree relatives with LFS-spectrum cancers are reasons to ask — not automatic diagnoses.
- Key note inside
Imaging and treatment
When feasible, teams may prefer lower-radiation strategies; choices are shared with oncology and genetics. Emergency surgery is not delayed solely for panels.
Family plan
Pathogenic TP53 findings open cascade testing and intensified surveillance pathways under counseling. This page does not replace those protocols.
- Key note inside
Important
This page is for education. It is not medical advice and does not replace a visit with your physician.
Frequently asked questions
Does every young cancer mean LFS?
No. Clinical criteria and family history set the counseling threshold.
Should emergency surgery wait for genetics?
No. Necessary emergency care proceeds; genetics informs later planning.
More chapters in this hub
Hereditary Cancer Overview
When hereditary risk is considered and how sequencing works
Lynch Syndrome
MMR/MSI, colorectal risk, and family screening
BRCA and Familial Breast Risk
Who is offered testing; surgery and surveillance frame
FAP
Polyposis, APC, and surgical timing
MUTYH and Serrated Polyposis
MAP, serrated pathway, and surveillance intervals
CDH1
Hereditary diffuse gastric cancer risk
Peutz–Jeghers Syndrome
Hamartomatous polyps and surveillance
Genetic Counseling
Consent, results, and talking with relatives
Molecular Testing in Cancer
Organ-specific biomarkers that often open this conversation
Appointment / info
This page is for education. It is not medical advice and does not replace a visit with your physician.
Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MD · Last medically reviewed: August 2026 · English patient-education chapter.